Table 3 Haematological toxicity (by patients and cycles)

From: A phase II study of paclitaxel and capecitabine as a first-line combination chemotherapy for advanced gastric cancer

 

Grade (% of patients, n =43) a

Grade (% of cycles, n =246) a

 

1

2

3

4

1

2

3

4

Anaemia

46.5

39.5

7.0

0

53.7

27.6

2.0

0

Leukopaenia

32.6

37.2

2.3

0

29.3

17.9

0.4

0

Neutropaeniab

9.3

20.9

39.5

7.0

12.2

19.5

19.1

1.6

Thrombocytopaenia

7.0

0

0

0

3.3

0

0

0

  1. aNCI CTC version 2.0.
  2. bNo febrile neutropaenia or treatment-related death.